Whole-genome DNA methylation sequencing provides both methylation patterns and genetic information. We utilized base resolution methylomes to directly identify allelic linkage of DNA methylation and genomic variants. The paired association was further extended to construct hepitypes by the simultaneous phasing of genotype and methylation. Using such approach, the sequencing reads provide direct statistics of the interdependence between methylcytosines and nucleotide variations; consequently, the detailed patterns of genetic and epigenetic variations can be readily inferred by data.
Introduction
DNA methylation is an important epigenetic mark, and it is involved in several cellular functions, including gene regulation [1] , genomic imprinting [2] , X chromosome inactivation [3] , cellular differentiation [4] , and suppression of transposable elements [5] . Three DNA methyltransferases, DNMT1, DNMT3A and DNMT3B, are responsible for de novo methylation and maintenance of existing methylation patterns [6] . Patterns of DNA methylation may change in different tissues, individuals and environments and at different developmental stages [7] . Aberrant DNA methylation is associated with many human diseases, including cancer [8] . Methylation of cytosines at promoter regions is often regarded as a repressive mark; hence, it is anticorrelated with the expression of associated genes [9] , [10] . Most cytosines in the human genome are unmethylated, except those in a CpG context [1] , [11] .
CpG methylation is widespread in the genome, with the exception of most CpG islands [2] , [12] , [13] .
Non-CpG methylation is detected in low quantity in mammalian embryonic stem cells and brain [3] , [14] - [17] .
DNA methylation can be measured by several experimental approaches, including MeDIP-Seq [4] , [18] , [19] , MRE-Seq [5] , [20] , RRBS [6] , [21] , and MethylC-Seq [7] , [22] , [23] . While each approach has its own advantages, MethylC-Seq is the most comprehensive method providing base resolution. Other approaches are comparatively less expensive, but they are often limited to certain locations or contexts; nonetheless, results of these different approaches have high concordance [8] , [24] .
Allele-specific DNA methylation (ASM) is a hallmark of imprinted regions [2] , [9] , [10] , [25] . ASM can also occur independent of parent-of-origin, but this type of variation is less well understood. For example, consider a locus that has two alleles distinguished by a single nucleotide variant (SNV), A/G, in which the cytosines in cis to the A allele are found to be more often methylated than those in cis to the G allele, as shown in a schematic example in Figure 1a . These differences in methylation patterns between two alleles can be strongly correlated with nearby genetic variation [26] . Such observation is regarded as an intriguing instance of allele-specific DNA methylation.
Recently, a number of studies utilized two different approaches to identify allele-specific DNA methylation [24] , [27] - [35] . One method uses SNP arrays [27] , [31] , [32] , and the other uses highthroughput sequencing by various methylation detection methods [24] , [28] - [30] , [35] . Few employ whole-genome bisulfite sequencing on one cell type [33] , [34] . Overall, dozens, to hundreds, of ASM sites, including the known imprinted regions, were identified, and about 75% of the ASM-related genes are associated with diseases [27] . In addition, ASM also exhibits cell type and individual differences [28] . When single nucleotide variants replace the C (cytosine nucleotide) or G (guanine nucleotide) in CpG sites, i.e., SNVs-in-CpG sites, the CpG dinucleotide is disrupted, allowing allele-specific DNA methylation to occur. This contributes to most of the identified allelic methylation pattern differences [30] .
Studies that used SNP arrays were limited to regions that contain known single nucleotide variants that were predesigned in the microarray. Thus, any sample-specific modifications were not detected.
Although this approach may be cost-effective, it is hard to infer comprehensive ASM at the individual level within a population. Methylation patterns detected by enzyme digestion often have low resolution, typically covering less than 5% of the genome; therefore, it is impossible to determine widespread ASM. Moreover, these data are further biased to specific genomic sites, further restricting the range of examined loci. On the other hand, although whole-genome bisulfite sequencing provides base resolution, none of the previous studies was able to provide detailed patterns of either genetic or methylation polymorphism beyond single sites.
Here, we propose an approach that identifies sequence-associated DNA methylation sites and haplotype-like epigenetic patterns, termed hepitypes [36] , utilizing data from whole-genome bisulfite sequencing. The use of base resolution methylome data has many advantages. First, the direct association between allele information and methylation patterns can be easily inferred by the bisulfiteconverted sequencing reads, which provide higher resolution than MeDIP-Seq [18] , [19] or MRE-Seq [20] ; thus, one dataset is sufficient to integrate both genetic and DNA methylation information.
Second, single nucleotide variants can be inferred directly from the sequencing data without limitation of known variants presented within databases, and additional genotyping is not required. Our method addresses short read lengths and incorporates multiple nucleotide variations and DNA methylation sites to specifically reconstruct hepitypes [27] , [36] , which currently is only possible using base resolution DNA methylomes.
As proof-of-principle, we tested our method on two cell lines, human embryonic stem cells (H1) and differentiated lung fibroblast cells (IMR90) [15] . We associated two polymorphic patterns, DNA methylation and nucleotide variation, by using only the methylomes. Since many of our findings agree with those of previous studies, we consider our method to be intrinsically validated. Furthermore, we determined that 10% of the detected ASM sites utilize cis-regulatory mechanisms, in addition to SNVin-CpG sites that harbor disrupted dinucleotide [30] . The former scenario, in which the SNV is proximal to the methylated cytosine, is of particular interest in this study. The results were used to estimate the percentages of conserved and cell type-specific ASM sites. This estimation reflects a mixture of cell line changes and real tissue differences. Because immortal cell lines often undergo epigenetic changes, they are only partially similar to the tissues from which they were originally derived; thus, the numbers can only be regarded as an in vitro estimation. Next, we built and ranked all possible hepitypes according to the observed frequency in the data. To the best of our knowledge, this is the first attempt to build hepitypes from bisulfite-converted methylomes in isolation. In the era of personalized medicine, 5 detailed hepitypes will shed further light on disease-associated susceptibilities and inter-individual differences. Finally, we show that ASM is partially associated with allele-specific expression (ASE) in that ASE can be related to both genetic and epigenetic factors. Our methods are applicable to many other types of high-throughput sequencing data for evaluating the interaction of genetic and epigenetic factors and can be used to extend genome-wide association studies (GWASs [37] ) to incorporate epigenetic variants (EWASs [38] ).
Experimental Details

Base resolution methylomes
The base-pair resolution methylomes [15] were downloaded from http://neomorph.salk.edu/human_methylome. The samples were treated with sodium bisulfite followed by next-generation sequencing. Methylated cytosines were not converted and remained as Cs; unmethylated cytosines were converted to uracils (Us) and became thymines (Ts) [39] . Other nucleotides were not affected. We utilized the analyzed datasets of methylcytosines and MethylC-Seq mapped reads. Both cell lines studied in [15] , H1 and IMR90, were investigated independently. Both X and Y chromosomes were excluded because the stochastic methylation in X chromosome inactivation is not related to sequence variation, and read depths were insufficient in Y chromosome to enable statistical analysis.
Identify sequence-dependent DNA methylcytosines
We considered the methylation pattern as a special type of single nucleotide variants, which is revealed in the bisulfite-treated samples. The cytosine has two variants: methylated, as indicated by the numbers of Cs, and unmethylated, as indicated by the number of Ts in the sequencing reads.
To detect nucleotide and methylation variants. We applied the binomial test to detect both variants. If there is a variant at one particular site, the null hypothesis holds that the observed frequency for one allele should be equal to 0.5 (Binom(x,n,p=0.5,two.sided) 
Constructing hepitypes by utilizing pair-wise association of genetic and epigenetic variants
To reconstruct broader regions having both genetic and epigenetic patterns, we decided to make use of the paired association results. If site A is associated with site B and site B is associated with site C, even though no direct relationship exists between sites A and C, the connection is inferred through site B.
We modified the traditional all-pairs-shortest-path algorithm [40] to construct possible hepitypes. This approach shows the detailed composition of nucleotides and DNA methylation patterns that cannot otherwise be obtained if joint probability is used. Joint probability only considers two locations and does not distinguish between specific nucleotides and methylation patterns, thus losing critical information.
We first built a simple directed graph, utilizing the pair-wise association information. The direction of the graph is inferred by the natural genomic locations of the sites (5' to 3'). Each position has two nodes. Each node represents either a nucleotide, e.g., A/G, if it is a SNV, or a methylation pattern, e.g., C/T, if it is a differentially methylated cytosine. If a significant association exists between nodes of two distinct locations, edges are added to link the corresponding nodes. There are no edges between nodes in the same position. The weight of an edge is the observed frequency of that pair of nodes. A path traversed via the edges along the graph yields a possible hepitype, i.e., a particular combination of genetic and epigenetic marks that occurred on the same segment of the genome.
A score is given to each path for ranking the hepitypes. The path with lowest score indicates that this hepitype has the highest frequency observed from the data. The score is calculated as follows:
, where x i is the i-th node at position x; y j is the j-th node at position y; cov(x i , y j ) is the number of reads supporting x i and y j ; and cov(x, y) is the total number of reads mapped at x and y. Top candidates are those with high frequencies, also representing the most probable hepitype to be observed in the dataset. Subsequent analysis on methylation spreading is done on the highest ranked hepitype only.
Transcription factor binding site prediction
To identify possible transcription factor binding sites (TFBSs), we downloaded the position weight matrixes (PWMs) of two transcription factors, CTCF and SP1, from the Jaspar [41] mammalian database. The PWMs were converted to scores and subsequently used to search against the human genome. Motifs of scores higher than zero were retained. Overlapping motifs, if any, were merged.
Random PWMs found by shuffling the columns of the specific PWMs were generated from Jaspar [41] 8 for each binding site and were used to search for nonspecific binding locations. This is more suitable than using the nearby regions of TFBSs as background for two reasons. First, data have shown that methylation has a spreading effect, and the affected region, including, but not limited to, TFBSs, could exhibit ASM. Second, a recent paper [26] put TFBSs in the center of methylation domains, which, in turn, inhibits DNA methylation. Thus, the sequences next to the binding sites are not suitable candidates for random testing. The randomized process was repeated twenty times.
Identification of genes that display allele-specific methylation or expression
ASM genes could be determined if any of the allele-specific methylcytosines were within the promoter or gene body. The promoter is limited to 2 kbp upstream of the transcriptional start site. RefSeq gene [42] annotation was used to determine gene locations and models. Mapped reads from RNA-Seq data [15] were directly used in the analysis. Because of the higher sequencing errors exhibited at the end of the reads, reads with a certain number of mismatches in the alignment were trimmed after the first mismatch. We used the SNVs predicted in ASM to guide the search of ASE loci. It is possible that we identified a heterozygous nucleotide variant in methylome data, but only one allele is presented in the RNA-Seq of the same cell line; this scenario is included because the other allele could have no expression at all. The percentage of the expression levels of each allele was estimated using the frequency from read coverage. The SNVs can be used unambiguously to assign methylation and expression values to corresponding alleles.
H1 whole-genome sequencing
Whole-genome sequence data for H1 was obtained from genomic DNA purified from Oct4+ cells (passages 32 and 35) acquired from Cellular Dynamics International (Madison, WI). The DNA was purified using a PureLink™ Genomic DNA Mini Kit (Invitrogen, Carlsbad, CA) and used to create one fragment DNA library and two "long mate-pair" DNA libraries, as described in the "Applied Biosystems SOLiD™ 4 System Library Preparation Guide" (Applied Biosystems, Foster City, CA). One mate-pair library spanned ~1.5 kbp inserts and was made from 15 µg of DNA, and the second mate-pair library 9 spanned ~5 kbp inserts and was made from 30 µg of DNA. The 1.5 kbp insert library was PCR-amplified 9 cycles, and the 5 kbp insert library was amplified 12 cycles prior to use in SOLiD™ 4 templated bead preparation. For each insert size, two full slides of 2 x 50 bp sequencing and 5 full slides of 1 x 50 bp sequencing were obtained on the SOLiD™ 4 System. The sequencing reads were mapped, and SNV calling was performed using the BioScope™ analysis system. Parameters for mapping were as follows: maximum hits=100, mismatch penalty= -2.0, minimum cutoff score for filtering= 0, clear zone = 5, and mismatch level = 6. SNV calling parameters were as follows: call stringency = medium, skip high coverage (het)= 1. The raw sequences were deposited to the Short Read Archive with ID SRA049981.
Caveats and limitations
Although we were able to directly detect the sequence-associated methylation sites and regions using base-resolution methylomes, several issues affect the result. First, the length of the reads depicts an upper boundary in identifying pairs of SNVs and partially methylated cytosines. Associated sites that are far apart from each other, i.e., beyond the read length, are undetectable. Second, some sites were excluded because of the low-quality sequencing scores and/or insufficient coverage. The coverage of the genome is not sufficient to provide statistical power to infer association in many locations. Third, the informative single nucleotide variants in studying allele-specific expression are limited because they need to be presented in the MethylC-Seq data, as well as the RNA-Seq data, in the transcribed regions.
Fourth, because ASM is cell type-dependent and individual-specific, comparison with other studies that make use of different cell lines is not straightforward. Here we were only able to detect ASM patterns when a heterozygous SNV was presented in the data. Other types of genetic variation, like insertion and deletion, though intriguing, were excluded in the analysis.
Results
Allele-specific DNA methylation is not limited to imprinting and CpG deamination
In addition to imprinted genes [2] and the inactive X chromosome [3] , a less understood, but broadly prevalent, type of allele-specific DNA methylation has been recently observed. In this configuration, two alleles have complementary methylation patterns and can be distinguished by single nucleotide variance, not by parent-of-origin [24] , [27] - [35] . Also, the DNA methylation status of the locus can be associated with nucleotide variants in the vicinity.
To facilitate understanding of genome-wide characteristics of allele-specific methylcytosines, we developed a straightforward computational method and applied it to the H1 and IMR90 methylomes [15] . Our approach assumes the availability of similar high-throughput sequencing data from bisulfitetreated samples so that both genetic and DNA methylation polymorphisms can be revealed in a single dataset. Such base resolution methylomes can provide an informative foundation for quantitative and direct inferences of associations between genotype and methylation polymorphisms. We used single nucleotide variants to separate two alleles and tested whether the local methylation patterns were significantly associated with the SNVs (Figure 1a ). In addition, we also tested whether methylation patterns of two cytosines are associated with each other (Experimental Details).
Numbers and patterns of the allele-specific methylcytosines in H1 and IMR90
We identified over 9000 potential allele-specific methylcytosines in H1 and IMR90 ( Figure 1b and Table   1 ). Over 800 ASM sites were identified in both cell lines, and more than half (56%) have the same direction of methylation, namely, the same allele shows higher methylation. This also indicates that the occurrence of ASM is not biased toward embryonic stem cells, but is a general phenomenon.
Most of the allele-specific methylcytosines (56% and 79% in H1 and IMR90, respectively) are CpG sites.
Over 65% and 19% in H1 and IMR90, respectively, were SNV-in-CpGs sites, a phenomenon which was also observed in other studies [30] , [32] . Two types of SNV-in-CpG sites were observed. In most casesthe A/G SNV followed the C, but in 645 and 382 sites in H1 and IMR90, respectively, the cytosine itself is a C/T SNV and is followed by a G in hg18. Monoallelic methylation is not surprising in these two cases because the CpG sites are the main targets of DNA methyltransferases, and disruption of the sites results in different methylation patterns.
In contrast, a small, but significant, proportion of allele-specific CpG sites, identified as having no disruption of their dinucleotide patterns, was strongly associated with proximal nucleotide variants, Furthermore, 4134 and 2952 ASM sites were non-CpG sites in H1 and IMR90, respectively. Non-CpG methylation in differentiated cells is reported in peripheral blood samples, albeit in small amounts of less than 0.2% [33] , and mouse brain tissues [17] . Of the small number of non-CpG methylation sites in IMR90, 1.9% showed allele-specific DNA methylation, in contrast to 0.05% in H1 (p < 2.2e-16,
prop.test). This indicates that methylated non-CpG sites are partially retained in differentiated cells
based on their role in allele-specific methylation patterns.
Distribution and locations of allele-specific methylcytosines in H1 and IMR90
We studied the distribution and locations of all ASM sites in the genome. Thirty-six percent was within 2 kbp of transcription start and termination sites. The percentages of each subregion, including promoter, exons, introns, 5'UTR and 3'UTR, are smaller, but not different from, the genomic average in either cell line. Of the genes that contain allele-specific methylcytosines, 1004 genes were found in both H1 and IMR90. They are not clustered into any specific disease type, but 255 ASM genes havedisease annotation according to the Online Mendelian Inheritance in Man (OMIM [43] ) or the Genetic Association Database (GAD [44] ), and many were involved with complex diseases, such as cancer-or neurological-related disorders. These results indicate that allele-specific methylated genes may play an important role in disease-related pathways, especially in sporadic complex diseases.
Specifically, there were 62 and 79 ASM sites in 17 and 18 CpG islands in H1 and IMR90, respectively.
Seven of these CpG islands were the same in both cell lines, indicating that some CpG islands, even though most are hypomethylated, exhibit ASM patterns and should be treated separately. Many CpG islands are associated with genes [1] , and an alteration of their methylation patterns is often seen in diseases [45] .
When compared to random occurrence, we found that ASM sites occurred significantly less often in methylation-sensitive transcription factor binding sites (TFBSs). Methylation differences may alter the binding affinity of transcription factors in cis-regulatory regions [46] . Thus, any ASM observed in TFBSs would most likely skew transcriptional differences. This increases the possibility of gene dysfunction, especially if both copies of the gene are needed or when one copy has already harbored mutations and is not functional. To avoid such skewing, TFBSs that are more sensitive to methylation are expected to contain fewer ASM sites. We used two methylation-sensitive TFBSs, CTCF and SP1, as examples (Experimental Details). We first observed that the number of ASM sites in TFBSs was lower than expected by chance, as noted above. Second, the more methylation-sensitive CTCF binding sites contain fewer ASM sites when compared to the less-sensitive SP1 binding sites (Figure 3 ; p < 0.0046 for CTCF and p < 0.1013 for SP1, z-score). No difference was found between CpG and non-CpG sites.
Therefore, our data provide evidence of constraints to ASM that limit possible transcriptional differences between two alleles.
Assembly of hepitypes by integrating genetic and methylation variants
We extended the analysis of single ASM sites to identify regions that have multiple ASM sites. To further understand the characteristics and functionalities of ASM sites and take advantage of base resolution methylomes, we reconstructed hepitypes using the results from previously identified ASM sites. The idea of the hepitype [36] was proposed previously as one of many explanations for complex diseases. When neither the haplotypes nor the epitypes [47] , [48] can be used to investigate the genetics behind human phenotypes, hepitypes can provide information that more clearly reveals the genetic/epigenetic mechanisms underlying disease susceptibility [49] . When several ASM sites and SNVs are associated with each other, one can infer and extend the complex hepitypes by exhaustively searching all possible combinations (Figure 4a) . A path traversed from 5' to 3' represents a hepitype;
the paths revealed the detailed composition of the genetic and DNA methylation patterns, which is only achievable using bisulfite-treated sequenced reads (Experimental Details).
A total of 8370 and 9202 ASM hepitypes were identified in H1 and IMR90, respectively. The average sizes were 5 bp and 7 bp, but when SNV-in-CpGs (2 bp) are excluded, the average sizes increased to 17 bp in H1 and 11 bp in IMR90, respectively, while 42 kbp and 61 kbp were covered in H1 and IMR90, respectively. Like SNV-in-CpG sites, many are short and isolated. The longest hepitype found in H1 was 89 bp in chr12, which included 10 sites. In IMR90, the longest was 95 bp in chr2 and included 6 sites.
These hepitypes were shorter compared to the sliding window blocks, and as a result, the number of regions was increased. This discrepancy is caused by the lack of coverage and short read lengths. Many ASM sites may be within 100 bp of each other; however, if no reads are mapped between any of these sites to support a direct association, then the phasing patterns cannot be assigned by our method. The reported hepitypes are shorter than traditionally defined haplotypes because we only used the pairs of nucleotide and methylation variants. Nonetheless, our method finds regions where the hepitypes are significantly different between two copies of the genome. We next ranked the hepitypes by the observed frequency such that higher frequencies were given higher ranks (Experimental Details). Only the longest and top-ranked hepitype was reported and selected for further analysis.
When one CpG site is methylated, its neighboring CpG sites are often methylated as well; this is known as the methylation spreading effect [50] . Whether ASM also exhibits a similar spreading effect is unknown. If all of the methylated cytosines are in one allele and the other allele contains only unmethylated cytosines, we hypothesized that the spreading mechanism plays a causal role in allelespecific DNA methylation. In contrast, if one allele has both methylated and unmethylated cytosines, this allele has a mixed methylation pattern. Using the hepitype results, we selected the top-ranked hepitype ( Figure 4b ) and limited our investigation to the regions where the number of allele-specific methylated sites is more than three. If the path contained only Cs or Ts, it suggests that spreading is taking place. Any other patterns were considered as mixed methylation. Many regions exhibited spreading methylation, as indicated in H1, with 78 out of 123 hepitypes, and IMR90, with 101 out of 15 110 hepitypes. Furthermore, in the mixed methylation hepitypes, many showed segmented behavior.
To illustrate, 35 out of 45 hepitypes and 8 out of 9 hepitypes in H1 and IM90, respectively, showed a continuous series of methylated Cs that switched to unmetylated Ts in the middle of alleles. Thus, the top-ranked hepitypes either have a spreading or a segmented methylation pattern, which indicates that at the allele level, methylation spreading is indeed a significant phenomenon (Figure 4b) .
Genes separated into two groups based on opposite correlations between allele-specific expression and allele-specific methylation in exons
Allele-specific gene expression (ASE) is one phenomenon that indicates complex transcription regulatory mechanisms for the mammalian genome, in addition to alternative splicing and dual-coding.
Moreover, ASE is widespread and may contribute to inter-individual differences [51] , [52] . The mechanism of ASE is, in part, related to allelic epigenetic marks [53] , as exemplified by imprinting [2] . If DNA methylation patterns are different between the alleles, we hypothesize that the patterns could be associated with differential allelic expression. Thus, to fully understand the degree of such correlations, we investigated the extent to which ASM is associated with ASE.
First, we utilized SNVs that were detected in bisulfite-treated reads. These sites must also be sequenced in mRNA, but not necessarily yield SNVs, to infer the correlation between ASM and ASE. A total of 471 and 210 informative SNVs were associated with 311 and 180 genes in H1 and IMR90, respectively. One SNV could have multiple gene annotations in RefSeq [42] , and we included all the gene identifiers in the list. We further took the high coverage SNVs that reside in exonic regions and examined the associated methylation levels with the expression levels. The data show two groups. One comprises 80% of the sites and has positive correlation between the expression and methylation levels, and the other 20% has negative correlation ( Figure 5 ). Table 2 shows the seventeen genes that exhibit allelic methylation and expression patterns in both H1
and IMR90. Several genes are of particular interest. PRIM2 and PRA2 are part of the DNA replication pathway. Methylation pattern differences between two alleles may affect timing and efficiency of DNA replication. CASC5 is identified as a cancer susceptibility candidate gene and part of a centromere complex [54] . Interestingly, another protein involved in the same complex, PMF1, is also an ASM gene, but it did not have ASE information in H1 by the lack of mRNA reads. We identified four non-coding RNA genes that have both ASM and ASE patterns. Two of them, MIR663A [55] and XPC [56] , are involved in cancer pathways. MicroRNA expression levels are different after treating cancer patients with two different drugs [57] . Thus, it is likely that allele-specific patterns play a role in the different responses of patients after cancer treatments.
Cross-validation with other studies
Finally, we cross-validated our analysis with other databases and studies. We first excluded the possibility that these sites are in imprinted regions. Twenty-one ASM CpG sites, but no ASM non-CpG sites, were in 8 out of 58 known imprinted loci [58] . While the comprehensive list of mammalian imprinted loci is still unknown, we showed that the presence of ASM sites specifically related to SNVs is more widespread and is a more distinct mechanism than imprinting.
Next, we compared our results with the instances reported by other studies using the same cell lines.
Using the embryonic stem cell line (H1), Harris et al. [24] identified 62 ASM regions in autosomes; ten regions are also listed in our survey. We did not find other regions, partly because of insufficient sequencing depth in our input methylomes. For example, the upstream SNV-in-CpG site of POTEB is not detected in our analysis because the CpG site has only three reads, which is lower than our minimal threshold. Another possibility is the likelihood that the experimental approach, MRE+MeDIP, will find allelic methylated regions without SNVs present, thus limiting the overlap, as observed in their results.
We also took the results from peripheral blood [33] and searched for consensus ASM genes. Twelvepercent, or 48 out of 394 ASM genes in their study, were also cataloged in our list, such as FANK1 and FRG1. Both of these genes have OMIM annotation, 611640 and 601278, indicating that ASM genes are important and that the DNA methylation patterns should be considered when studying complex diseases.
Moreover, the H1 genome is sequenced separately, and we compared the SNV calls from the genomic sequencing (Experimental Details) with the nucleotide variants identified in this study. Seventy-nine percent of the variants were annotated as SNVs in H1. Our method predicted at least 79% of the methylation-associated SNVs correctly. About 10% of the inconsistencies were in SNV-in-CpG sites, and an additional 5% of the methylome SNVs were C/T alleles, but the reference genome has a T nucleotide. It is possible to attribute these inconsistencies in 15% of methylome SNVs to bisulfiteconversion, incorrect mapping or other unknown reasons. The remaining 6% of the inconsistencies do not have any specific pattern, and further investigation is needed to determine the cause. These results indicate that our straightforward approach in searching nucleotide variants is sufficient, but needs to be taken with a cautionary note.
Discussion
Allele-specific methylation, other than imprinted loci, is a recently recognized characteristic of human epigenomes because of newly available data types [59] . ASM is independent from the imprinting mechanism, in which methylation patterns are determined by parent-of-origin. For a number of cytosines, it was shown that the methylation patterns are quantitatively associated with nearby genetic variants. As a simple example, for CpG sites that carry SNVs, the alleles exhibit CpG/CpH/DpG polymorphism, i.e., H as non-G and D as non-C nucleotides. The methylation difference most likely results from the disruption of CpG sites. However, the more intriguing case involves the strong association between SNV and CpG sites from a distance. In this case, the CpG context is preserved, and the SNVs are in the vicinity of the methylcytosines.
Local sequence variation may affect methylation patterns in several ways. Biophysical experiments indicate that sequence differences affect the double helix structure around the methylated sites [60] .
Moreover, if the ASM sites reside in protein binding sites, causing methylation-sensitive proteins to bind preferentially to one allele over another, subsequent events could result in skewing expression of the two alleles [61] . We observed that ASM sites are less likely to occur in such binding sites, especially if the corresponding DNA-binding proteins are methylation-sensitive. A recent study showed that the binding of transcription factors affects local DNA methylation patterns, which provides indirect experimental evidence of our hypothesis [26] .
Several examples have revealed the importance of associations between genetic and epigenetic variants. For example, the frequency of a specific haplotype, which is significantly increased in patients with Beckwith-Wiedemann syndrome (MIM130650), is, in turn, associated with the loss of methylation in one of the key loci [62] . Recently, methylation analyses on diabetes and obesity-related loci have
shown that the aberrant methylation patterns were driven by single nucleotide polymorphism (SNP) [48] , [63] . As discussed in this paper, hepitypes would be useful in studying susceptibility of such complex diseases [64] .
A number of genes exhibit both allele-specific methylation and expression [65] . We collected SNVs that were sequenced in methylomes, and these sites must also be sequenced in the expression data. While only a limited number of such informative SNVs are available, most of these genes are positively correlated between expression and exon methylation levels, and in the major alleles with higher expression values, the expression value is predictive of the methylation value. In contrast, when the allele has methylation lower than 0.2, there is virtually no correlation with expression. Part of our results determined the association between ASE and ASM. Specifically, it was found that genes could beseparated into two groups according to their correlation between expression and methylation. One group contains more genes and has a positive correlation between expression and methylation; the other has fewer genes and virtually no correlation. In future studies, ASE will present essential information for revealing the possible consequences of any cis-regulatory and allelic mechanisms [51] , [66] .
Conclusion
We proposed an integrated approach to analyzing the base-pair methylomes in order to understand the interaction between genetics and epigenetics. Specifically, we provide examples and demonstrate the capacity to extend the analyses from haplotypes to hepitypes. The pipeline is easy to expand and to incorporate other next-generation sequencing data, such as histone modifications and chromatin structures [67] , [68] . Integration of different sources of data is important in understanding not only the role of individual marks, but also combinatorial sets of the marks. The next step is to integrate predefined linkage disequilibrium blocks with low-resolution methylation results. This will free the current requirement of base-pair resolution data and is advantageous for large population studies [52] . Finally, integrating epigenetic marks with genome-wide association studies will aid in the identification of disease-related markers and regions [38] .
ASM is both cell-and tissue-specific, providing additional layers of variability in gene regulation. Thus, when studying population genetics, health and evolution, epigenetic information should be incorporated [38] . Our results shed light on potential regulatory roles of non-coding SNVs in the domain of epigenomics. Genetic variations alone cannot explain the full spectrum of sporadic complex diseases [37] . The combinatorial effect of genetic and epigenetic patterns is likely an important factor and should be considered in more genetic studies, as it can provide information on disease susceptibility at the level of personalized medicine.
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